| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.5 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.5 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |